During the past decade, Kinshasa School of Public Health conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kinshasa School of Public Health" #1 sponsor was "NICHD Global Network for Women's and Children's Health" with 6 trials, followed by "University of North Carolina, Chapel Hill" with 4 trials sponsored, "Medicines for Malaria Venture" with 3 trials sponsored, "University of Oxford" with 3 trials sponsored and "Albert Einstein College of Medicine" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kinshasa School of Public Health" #1 collaborator was "Kinshasa School of Public Health" with 11 trials as a collaborator, "Bill and Melinda Gates Foundation" with 5 trials as a collaborator, "RTI International" with 4 trials as a collaborator, "Thomas Jefferson University" with 4 trials as a collaborator and "Aga Khan University" with 3 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Kinshasa School of Public Health" are "Malaria" (3 trials), "Malnutrition" (2 trials), "Stunting of Growth" (2 trials), "Anaemia" (1 trials) and "Antiretroviral Therapy" (1 trials). Many other conditions were trialed in "Kinshasa School of Public Health" in a lesser frequency.

Most popular intervention types in "Kinshasa School of Public Health" are "Drug" (12 trials), "Behavioral" (3 trials), "Dietary Supplement" (3 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Artefenomel 800mg: piperaquine 1440mg" (1 trials), "Artefenomel 800mg: piperaquine 640mg" (1 trials), "Artefenomel 800mg: piperaquine 960mg" (1 trials) and "Artemether-lumefantrine + placebo (AL+PBO)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kinshasa School of Public Health" are 15 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Kinshasa School of Public Health". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Kinshasa School of Public Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kinshasa School of Public Health, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".

Kinshasa School of Public Health has several departments that took part in Clinical trials: "Kinshasa Medical Oxford Research Unit" - 2 trials